All news

Alembic Pharma Q2 profit jumps 81.46% to Rs 335 crore as US formulations rise 77%

Upstox · · AI-summarised by FinFlash

Alembic Pharma reported consolidated second-quarter net profit of Rs 335 crore, up 81.46% from Rs 184.7 crore a year earlier. Revenue rose 36.3% to Rs 2,603.48 crore, with US formulations sales climbing 77%. The result arrived among a heavy slate of Indian earnings, with close to 300 companies due to report September-quarter numbers on Thursday, and as Indian benchmarks pointed to a strong open after the US midterm outcome.

So What?

Adds to strong US-driven prints among Indian generics after Aurobindo's record quarter, though Thursday's market saw pharma and healthcare lag. Watch US pricing commentary.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.